Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

August 28, 2015

Merck Sharp & Dohme Corp. v. Royalty Pharma Collection Trust

Track this case

Case Number:

1:15-cv-00757

Court:

Delaware

Nature of Suit:

Patent

Judge:

Gregory M. Sleet

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 31, 2015

    Merck Seeks Stop Of Royalty Payments For Diabetes Patents

    Merck Sharp & Dohme Corp. on Friday asked a Delaware federal judge to either invalidate or find it no longer needs to pay royalties on 10 patents related to its Januvia and Janumet treatments for Type II diabetes, arguing the patents were either invalid or not specific enough to warrant continued payments.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login